Andrew Pecora, M.D., F.A.C.P
2021
In 2021, Andrew Pecora, M.D., F.A.C.P earned a total compensation of $9.1M as President at Celularity.
Compensation breakdown
| Option Awards | $8,398,741 |
|---|---|
| Salary | $262,506 |
| Other | $389,750 |
| Total | $9,050,997 |
FACP received $8.4M in option awards, accounting for 93% of the total pay in 2021.
FACP also received $262.5K in salary and $389.8K in other compensation.
Rankings
In 2021, Andrew Pecora, M.D., F.A.C.P's compensation ranked 1,214th out of 12,415 executives tracked by ExecPay. In other words, FACP earned more than 90.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,214 out of 12,415 | 90th |
Division Manufacturing | 429 out of 5,505 | 92nd |
Major group Chemicals And Allied Products | 154 out of 2,375 | 94th |
Industry group Drugs | 128 out of 2,096 | 94th |
Industry Pharmaceutical Preparations | 85 out of 1,546 | 95th |
Source: SEC filing on June 3, 2022.
FACP's colleagues
We found three more compensation records of executives who worked with Andrew Pecora, M.D., F.A.C.P at Celularity in 2021.